Advertisement

Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists’ and Patients’ Perspectives

  • Eskinder Eshetu Ali
  • Sharlene Si Ling Chan
  • Huan Yu Poh
  • Yosua Amadeus Susanto
  • Thendral Suganya
  • Jo Lene Leow
  • Chee Khiang Pang
  • Lita Chew
  • Kevin Yi-Lwern YapEmail author
Mobile & Wireless Health
  • 19 Downloads
Part of the following topical collections:
  1. Mobile & Wireless Health

Abstract

Smartphone apps can potentially help in enhancing oral anticancer medication (OAM) adherence. Patient adoption and efficacy of such apps depends on inclusion of user-centred and evidence-based features. The objective of this study was to identify important design considerations from the perspectives of patients taking OAMs, caregivers and oncology pharmacists. The study employed a qualitative study design. Data were collected using in-depth interviews with patients (n = 15), caregivers (n = 3) and pharmacists (n = 16). Interviews were audio-recorded, transcribed verbatim and inductive thematic analysis approach was used in data analysis. Monitoring medication-related problems, medication information, replacement of or integration with current systems and accessibility of app content on devices other than smartphones were the key themes identified in the analysis. Flexible input methods for monitored data, glanceability of monitored reports/information, near real-time adherence enhancing and symptom management interventions and customisable reminder options were design considerations identified under the monitoring medication-related problems theme. Participants suggested the provision of focused and easily understandable medication information with a potential for personalisation. Integration of app-based adherence systems with patients’ electronic medical records with added mechanisms for alerts in the dispensing system was also suggested as a key design requirement to improve quality of patient care and facilitate adoption by clinicians. Finally, smartphones were the most favoured platform with optional accessibility of app content on other devices. In conclusion, important design considerations were identified through a user-centred design approach. The findings will help developers and clinicians in the design of new app-based systems and evaluation of existing ones.

Keywords

Adherence apps Medication adherence User-centred design Design requirement Oral anticancer medication 

Notes

References

  1. 1.
    Sabaté, E., Adherence to long-term therapies: Evidence for action. Switzerland: World Health Organization, 2003.Google Scholar
  2. 2.
    Barillet, M., Prevost, V., Joly, F., and Clarisse, B., Oral antineoplastic agents: How do we care about adherence? Br. J. Clin. Pharmacol. 80(6):1289–1302, 2015.CrossRefGoogle Scholar
  3. 3.
    Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., Lennes, I., Temel, J. S., Safren, S. A., and Pirl, W. F., A systematic review of adherence to oral antineoplastic therapies. Oncologist 21(3):354–376, 2016.CrossRefGoogle Scholar
  4. 4.
    Huang, W. C., Chen, C. Y., Lin, S. J., and Chang, C. S., Medication adherence to oral anticancer drugs: Systematic review. Expert Rev. Anticancer Ther. 16(4):423–432, 2016.CrossRefGoogle Scholar
  5. 5.
    Shafrin, J., Sullivan, J., Chou, J. W., Neely, M. N., Doan, J. F., and Maclean, J. R., The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma. Cancer Manag. Res. 9:731–739, 2017.CrossRefGoogle Scholar
  6. 6.
    Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Lang, I., Colleoni, M., and Thurlimann, B., Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence. J. Clin. Oncol. 34(21):2452–2459, 2016.CrossRefGoogle Scholar
  7. 7.
    Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., and Garcia-Cardenas, V., Economic impact of medication nonadherence by disease groups: A systematic review. BMJ Open 8:e016982, 2018.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Latremouille-Viau, D., Guerin, A., Gagnon-Sanschagrin, P., Dea, K., Cohen, B. G., and Joseph, G. J., Health care resource utilization and costs in patients with chronic myeloid leukemia with better adherence to tyrosine kinase inhibitors and increased molecular monitoring frequency. J. Manag. Care Spec. Pharm. 23(2):214–224, 2017.PubMedGoogle Scholar
  9. 9.
    Gandhi, S., Day, L., Paramsothy, T., Giotis, A., Ford, M., Boudreau, A., and Pasetka, M., Oral anticancer medication adherence, toxicity reporting, and counseling: A study comparing health care providers and patients. J. Oncol. Pract. 11(6):498–504, 2015.CrossRefGoogle Scholar
  10. 10.
    Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., and Van Hecke, A., Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treat. Rev. 39(6):610–621, 2013.CrossRefGoogle Scholar
  11. 11.
    Foulon, V., Schoffski, P., and Wolter, P., Patient adherence to oral anticancer drugs: An emerging issue in modern oncology. Acta Clin. Belg. 66(2):85–96, 2011.PubMedGoogle Scholar
  12. 12.
    Car, L. T., Papachristou, N., Urch, C., Majeed, A., Atun, R., Car, J., and Vincent, C., Prioritizing medication safety in care of people with cancer: Clinicians’ views on main problems and solutions. J. Glob. Health 7 (1), 2017.  https://doi.org/10.7189/jogh.07.011001.
  13. 13.
    Hershman, D. L., Sticking to it: Improving outcomes by increasing adherence. J. Clin. Oncol. 34(21):2440–2442, 2016.CrossRefGoogle Scholar
  14. 14.
    Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., Barni, S., and Deschamp, V., The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (cariatide) study. Breast 23(4):393–399, 2014.CrossRefGoogle Scholar
  15. 15.
    Gebbia, V., Bellavia, M., Banna, G. L., Russo, P., Ferrau, F., Tralongo, P., and Borsellino, N., Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer. Clin. Lung Cancer 14(4):390–398, 2013.CrossRefGoogle Scholar
  16. 16.
    Mathes, T., Antoine, S.-L., Pieper, D., and Eikermann, M., Adherence enhancing interventions for oral anticancer agents: A systematic review. Cancer Treat. Rev. 40(1):102–108, 2014.CrossRefGoogle Scholar
  17. 17.
    Sommers, R. M., Miller, K., and Berry, D. L., Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol. Nurs. Forum 39(4):E373–E379, 2012.CrossRefGoogle Scholar
  18. 18.
    Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Luck, H. J., Windemuth-Kieselbach, C., Zaun, S., and Kreienberg, R., The patient's anastrozole compliance to therapy (pact) program: A randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann. Oncol. 24(6):1505–1512, 2013.CrossRefGoogle Scholar
  19. 19.
    Kav, S., and Tokdemir, G., The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy. Asia Pac. J. Oncol. Nurs. 4(4):290, 2017.CrossRefGoogle Scholar
  20. 20.
    Spoelstra, S. L., Given, C. W., Sikorskii, A., Coursaris, C. K., Majumder, A., DeKoekkoek, T., Schueller, M., and Given, B. A., Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: A randomized controlled trial. Telemed. J. E Health 22(6):497–506, 2016.CrossRefGoogle Scholar
  21. 21.
    Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., and Haynes, R.B., Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. (11):Cd000011, 2014.Google Scholar
  22. 22.
    Car, J., Tan, W. S., Huang, Z., Sloot, P., and Franklin, B. D., Ehealth in the future of medications management: Personalisation, monitoring and adherence. BMC Med. 15(1):73, 2017.CrossRefGoogle Scholar
  23. 23.
    Deloitte., Mobile multiplies: Global mobile consumer survey, 2015. https://www2.deloitte.com/content/dam/Deloitte/sg/Documents/technology-media-telecommunications/sg-tmt-global-mobile-consumer-survey-noexp.pdf. Accessed 14 December 2015.
  24. 24.
    Pew Research Center., Smartphone ownership and internet usage continues to climb in emerging economies, 2016. http://www.pewglobal.org/files/2016/02/pew_research_center_global_technology_report_final_february_22__2016.pdf. Accessed 31 August 2016.
  25. 25.
    Ali, E. E., Leow, J. L., Chew, L., and Yap, K. Y., Patients' perception of app-based educational and behavioural interventions for enhancing oral anticancer medication adherence. J. Cancer Educ., 2017.  https://doi.org/10.1007/s13187-017-1248-x.
  26. 26.
    Haase, J., Farris, K. B., and Dorsch, M. P., Mobile applications to improve medication adherence. Telemed. J. E Health 23(2):75–79, 2017.CrossRefGoogle Scholar
  27. 27.
    Spoelstra, S. L., and Sansoucie, H., Putting evidence into practice: Evidence-based interventions for oral agents for cancer. Clin. J. Oncol. Nurs. 19(3 Suppl):60–72, 2015.CrossRefGoogle Scholar
  28. 28.
    Tricarico, C., Peters, R., Som, A., Javaherian, K., and Ross, W., Epxmedtracking: Feasibility evaluation of an sms-based medication adherence tracking system in community practice. JMIR Res. Protoc. 6(5):e87, 2017.CrossRefGoogle Scholar
  29. 29.
    Marcum, Z. A., Sevick, M. A., and Handler, S. M., Medication nonadherence: A diagnosable and treatable medical condition. JAMA 309(20):2105–2106, 2013.CrossRefGoogle Scholar
  30. 30.
    de Vries, S. T., Denig, P., Lasheras Ruiz, C., Houyez, F., Wong, L., Sutcliffe, A., PGM, M., and Consortium IMIW-RWPb, Interest in a mobile app for two-way risk communication: A survey study among european healthcare professionals and patients. Drug Saf., 2018.  https://doi.org/10.1007/s40264-018-0648-0.
  31. 31.
    Berkowitz, C. M., Zullig, L. L., Koontz, B. F., and Smith, S. K., Prescribing an app? Oncology providers’ views on mobile health apps for cancer care. JCO Clin. Cancer Inform. 1 (1), 2017.  https://doi.org/10.1200/CCI.17.00107.
  32. 32.
    Azevedo, R., Bernardes, M., Fonseca, J., and Lima, A., Smartphone application for rheumatoid arthritis self-management: Cross-sectional study revealed the usefulness, willingness to use and patients' needs. Rheumatol. Int. 35(10):1675–1685, 2015.CrossRefGoogle Scholar
  33. 33.
    Israni, A., Dean, C., Kasel, B., Berndt, L., Wildebush, W., and Wang, C. J., Why do patients forget to take immunosuppression medications and miss appointments: Can a mobile phone app help? JMIR Publ. Health Surveill. 2(1):e15, 2016.CrossRefGoogle Scholar
  34. 34.
    Kessel, K. A., Vogel, M. M., Schmidt-Graf, F., and Combs, S. E., Mobile apps in oncology: A survey on health care professionals' attitude toward telemedicine, mhealth, and oncological apps. J. Med. Internet Res. 18(11):e312, 2016.CrossRefGoogle Scholar
  35. 35.
    Kessel KA, Vogel MME, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Schmid RM, Combs SE (2017) Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth 5 (6):e81.Google Scholar
  36. 36.
    Ali, E. E., Teo, A. K. S., Goh, S. X. L., Chew, L., and Yap, K. Y., MedAd-AppQ: A quality assessment tool for medication adherence apps on iOS and Android platforms. Res. Soc. Adm. Pharm. 14:1125–1133, 2018.Google Scholar
  37. 37.
    Dayer, L. E., Shilling, R., Van Valkenburg, M., Martin, B. C., Gubbins, P. O., Hadden, K., and Heldenbrand, S., Assessing the medication adherence app marketplace from the health professional and consumer vantage points. JMIR Mhealth Uhealth 5(4):e45, 2017.CrossRefGoogle Scholar
  38. 38.
    Santo, K., Richtering, S. S., Chalmers, J., Thiagalingam, A., Chow, C. K., and Redfern, J., Mobile phone apps to improve medication adherence: A systematic stepwise process to identify high-quality apps. JMIR Mhealth Uhealth 4(4):e132, 2016.CrossRefGoogle Scholar
  39. 39.
    Ahmed, I., Ahmad, N. S., Ali, S., Ali, S., George, A., Saleem Danish, H., Uppal, E., Soo, J., Mobasheri, M. H., King, D., Cox, B., and Darzi, A., Medication adherence apps: Review and content analysis. JMIR Mhealth Uhealth 6(3):e62, 2018.CrossRefGoogle Scholar
  40. 40.
    McCurdie, T., Taneva, S., Casselman, M., Yeung, M., McDaniel, C., Ho, W., and Cafazzo, J., Mhealth consumer apps: The case for user-centered design. Biomed. Instrum. Technol. 46(S2):49–56, 2012.CrossRefGoogle Scholar
  41. 41.
    Bernhard, G., Mahler, C., Seidling, H. M., Stützle, M., Ose, D., Baudendistel, I., Wensing, M., and Szecsenyi, J., Developing a shared patient-centered, web-based medication platform for type 2 diabetes patients and their health care providers: Qualitative study on user requirements. J. Med. Internet Res. 20(3):e105, 2018.CrossRefGoogle Scholar
  42. 42.
    Williamson, S. S., Gorman, P. N., and Jimison, H. B., A mobile/web app for long distance caregivers of older adults: Functional requirements and design implications from a user centered design process. AMIA Annu. Symp. Proc. 2014:1960–1969, 2014.Google Scholar
  43. 43.
    Paolella, G. A., Boyd, A. D., Wirth, S. M., Cuellar, S., Venepalli, N. K., and Crawford, S. Y., Adherence to oral anticancer medications: Evolving interprofessional roles and pharmacist workforce considerations. Pharmacy (Basel, Switzerland) 6(1):23, 2018.Google Scholar
  44. 44.
    Hsu, G. I.-H., Crawford, S. Y., Paolella, G., Cuellar, S., Wirth, S. M., Venepalli, N. K., Wang, E., Hughes, D., and Boyd, A. D., Design of customized mobile application for patient adherence to oral anticancer medications utilizing user-centered design. J. Biocommun. 41(1):5–14, 2017.Google Scholar
  45. 45.
    Fishbein, J. N., Nisotel, L. E., MacDonald, J. J., Amoyal Pensak, N., Jacobs, J. M., Flanagan, C., Jethwani, K., and Greer, J. A., Mobile application to promote adherence to oral chemotherapy and symptom management: A protocol for design and development. JMIR Res. Protoc. 6(4):e62, 2017.CrossRefGoogle Scholar
  46. 46.
    Whiteley, L., Brown, L., Lally, M., Heck, N., and van den Berg, J. J., A mobile gaming intervention to increase adherence to antiretroviral treatment for youth living with hiv: Development guided by the information, motivation, and behavioral skills model. JMIR Mhealth Uhealth 6(4):e96, 2018.CrossRefGoogle Scholar
  47. 47.
    Groshek, M. R., Oldenburg, J., Sarasohn-Kahn, J., and Sitler, B., Mhealth app essentials: Patient engagement, considerations, and implementation. Healthcare Information and Management Systems Society (HIMSS), 2015. http://www.himss.org/mhealth-app-essentials-patient-engagement-considerations-and-implementation?ItemNumber=39175. Accessed 17 March 2018.
  48. 48.
    Fraccaro, P., Vigo, M., Balatsoukas, P., van der Veer, S. N., Hassan, L., Williams, R., Wood, G., Sinha, S., Buchan, I., and Peek, N., Presentation of laboratory test results in patient portals: Influence of interface design on risk interpretation and visual search behaviour. BMC Med. Inform. Decis. Mak. 18(1):11, 2018.CrossRefGoogle Scholar
  49. 49.
    Ali, E. E., Cheung, K. L., Lee, C. P., Leow, J. L., Yap, K. Y., and Chew, L., Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore. Asia Pac. J. Oncol. Nurs. 4(4):283–289, 2017.CrossRefGoogle Scholar
  50. 50.
    Braun, V., and Clarke, V., Using thematic analysis in psychology. Qual. Res. Psychol. 3(2):77–101, 2006.CrossRefGoogle Scholar
  51. 51.
    Huang, R., Rqda: R-based qualitative data analysis. R package version 3.3.2, 2016. http://rqda.r-forge.r-project.org/. Accessed 7 February 2017.
  52. 52.
    Mirkovic, J., Kaufman, D. R., and Ruland, C. M., Supporting cancer patients in illness management: Usability evaluation of a mobile app. JMIR Mhealth Uhealth 2(3):e33, 2014.CrossRefGoogle Scholar
  53. 53.
    Darlow, S., and Wen, K.-Y., Development testing of mobile health interventions for cancer patient self-management: A review. Health Inform. J 22(3):633–650, 2016.CrossRefGoogle Scholar
  54. 54.
    Whittaker, R., Merry, S., Dorey, E., and Maddison, R., A development and evaluation process for mhealth interventions: Examples from New Zealand. J. Health. Commun. 17(Suppl 1):11–21, 2012.CrossRefGoogle Scholar
  55. 55.
    Nielsen, J., 10 usability heuristics for user interface design, 1995. https://www.nngroup.com/articles/ten-usability-heuristics/. Accessed 12 September 2017.
  56. 56.
    Joyce, G., Lilley, M., Barker, T., and Jefferies, A., Mobile application usability: Heuristic evaluation and evaluation of heuristics. In: Advances in human factors, software, and systems engineering. Springer International Publishing, 77–86, 2016.Google Scholar
  57. 57.
    Alpert, J. M., Morris, B. B., Thomson, M. D., Matin, K., and Brown, R. F., Implications of patient portal transparency in oncology: Qualitative interview study on the experiences of patients, oncologists, and medical informaticists. JMIR Cancer 4(1):e5, 2018.CrossRefGoogle Scholar
  58. 58.
    Finitsis, D. J., Pellowski, J. A., and Johnson, B. T., Text message intervention designs to promote adherence to antiretroviral therapy (art): A meta-analysis of randomized controlled trials. PloS One 9(2):e88166, 2014.CrossRefGoogle Scholar
  59. 59.
    Liu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., Liu, M., Chen, R., Chi, J., Lu, J., Huan, S., Cheng, S., Wang, L., Jiang, S., Chin, D. P., and Fielding, K. L., Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: A cluster-randomised trial. PLoS Med. 12(9):e1001876, 2015.CrossRefGoogle Scholar
  60. 60.
    Koster ES, Philbert D, van Dijk L, Rademakers J, de Smet P, Bouvy ML, Vervloet M (2018) Recognizing pharmaceutical illiteracy in community pharmacy: Agreement between a practice-based interview guide and questionnaire based assessment. Res. Soc. Admin. Pharm. : RSAP.  https://doi.org/10.1016/j.sapharm.2018.01.009
  61. 61.
    Godlee, F., Too much information. BMJ 349:g5153–g5153, 2014.CrossRefGoogle Scholar
  62. 62.
    Cheng, C., and Dunn, M., How well are health information websites displayed on mobile phones? Implications for the readability of health information. Health Promot. J. Austr. 28(1):15–20, 2017.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Eskinder Eshetu Ali
    • 1
  • Sharlene Si Ling Chan
    • 1
  • Huan Yu Poh
    • 2
  • Yosua Amadeus Susanto
    • 2
  • Thendral Suganya
    • 1
  • Jo Lene Leow
    • 3
  • Chee Khiang Pang
    • 2
    • 4
  • Lita Chew
    • 1
    • 3
  • Kevin Yi-Lwern Yap
    • 5
    Email author
  1. 1.Department of Pharmacy, Faculty of ScienceNational University of SingaporeSingaporeSingapore
  2. 2.Department of Electrical and Computer Engineering, Faculty of EngineeringNational University of SingaporeSingaporeSingapore
  3. 3.Department of PharmacyNational Cancer Centre SingaporeSingaporeSingapore
  4. 4.Engineering ClusterSingapore Institute of TechnologySingaporeSingapore
  5. 5.Department of Public Health, School of Psychology and Public HealthLa Trobe UniversityMelbourneAustralia

Personalised recommendations